Genetic Testing and Alzheimer Disease: Recommendations of the Stanford Program in Genomics, Ethics, and Society
Authors:
- Barbara A. KoenigBKBarbara A. Koenig
- Henry T. GreelyHGHenry T. Greely
- Thomas A. RaffinTRThomas A. Raffin
- 1 January 1999
- journal article
- research article
- Published by SAGE Publications in Genetic Testing
- Vol. 3 (1) , 3-12
Abstract
Several genes associated with Alzheimer disease (AD) have been localized and cloned; two genetic tests are already commercially available, and new tests are being developed. Genetic testing for AD—either for disease prediction or for diagnosis—raises critical ethical concerns. The multidisciplinary Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics, and Society (PGES) presents comprehensive recommendations on genetic testing for AD. The Group concludes that under current conditions, genetic testing for AD prediction or diagnosis is only rarely appropriate. Criteria for judging the readiness of a test for introduction into routine clinical practice typically rely heavily on evaluation of technical efficacy. PGES recommends a broader and more comprehensive approach, considering: 1) the unique social and historical meanings of AD; 2) the availability of procedures to promote good surrogate decision making for incompetent patients and to safeguard confidentiality; 3) access to sophisticated genetic counselors able to communicate complex risk information and effectively convey the social costs and psychological burdens of testing, such as unintentional disclosure of predictive genetic information to family members; 4) protection from inappropriate advertising and marketing of genetic tests; and 5) recognition of the need for public education about the meaning and usefulness of predictive and diagnostic tests for AD. In this special issue of Genetic Testing, the PGES recommendations are published along with comprehensive background papers authored by Working Group members.Keywords
This publication has 33 references indexed in Scilit:
- Decision Analysis and Alzheimer Disease: Three Case StudiesGenetic Testing, 1999
- Understanding Genetic Testing for Alzheimer Disease: Medical and Epidemiological BackgroundGenetic Testing, 1999
- High School Genetics Education and Alzheimer DiseaseGenetic Testing, 1999
- A Philosophical Critique of Decision Analysis as a Tool in Genetic TestingGenetic Testing, 1999
- The Application of Medical Decision Analysis to Genetic Testing: An IntroductionGenetic Testing, 1999
- Genetic Testing, Alzheimer Disease, and Long-Term Care InsuranceGenetic Testing, 1999
- Special Issues in Genetic Testing for Alzheimer DiseaseGenetic Testing, 1999
- Alzheimer's disease after remote head injury: an incidence study.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Consensus Statement on Predictive Testing for Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1995
- The role of apolipoprotein E genetic variants in lipoprotein disordersJournal of Internal Medicine, 1992